Quick Answer
CORCEPT THERAPEUTICS INC reported Revenue (ASC 606) of $761.41 million for fiscal year 2025.
CORCEPT THERAPEUTICS INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $761.41M | +12.8% |
| 2024 | $675.04M | +39.9% |
| 2023 | $482.38M | +20.0% |
| 2022 | $401.86M | +9.8% |
| 2021 | $365.98M | +3.4% |
| 2020 | $353.87M | +15.5% |
| 2019 | $306.49M | +22.0% |
| 2018 | $251.25M | +57.8% |
| 2017 | $159.20M | +95.8% |
| 2016 | $81.32M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $207.64M | +13.7% | +6.8% |
| June 30, 2025 | $194.43M | +18.7% | +23.7% |
| March 31, 2025 | $157.21M | +7.1% | -13.9% |
| September 30, 2024 | $182.55M | +47.7% | +11.4% |
| June 30, 2024 | $163.80M | +39.1% | +11.6% |
| March 31, 2024 | $146.81M | +39.0% | +18.8% |
| September 30, 2023 | $123.60M | +21.5% | +5.0% |
| June 30, 2023 | $117.72M | +13.9% | +11.4% |
- CORCEPT THERAPEUTICS INC showed an increase of +12.8% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, CORCEPT THERAPEUTICS INC’s revenue (asc 606) has grown by 836.3% (from $81.32 million to $761.41 million).
- The most recent figure is from CORCEPT THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: